David H. Deming
Director · Phio Pharmaceuticals Corp.
Individual
- 2025
- Feb 6, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David H. Deming files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert J. Bitterman - $45K in PHIO purchases and sales in the last 12 months
- Ronald Todd Plott - $27K in PHIO purchases and sales in the last 12 months
- Patricia A. Bradford - $19K in PHIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David H. Deming?
David H. Deming is a corporate insider, tracked as Director of Phio Pharmaceuticals Corp. (PHIO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David H. Deming last file a Form 4?
The most recent primary Form 4 on record is dated 6 February 2026, one of 2 filings going back to 2025.
